Canada - English - Health Canada

modern veterinary therapeutics llc - selamectin - solution - 60mg - selamectin 60mg - dogs

Canada - English - Health Canada

modern veterinary therapeutics llc - selamectin - solution - 120mg - selamectin 120mg - dogs

Canada - English - Health Canada

modern veterinary therapeutics llc - selamectin - solution - 240mg - selamectin 240mg - dogs

Canada - English - Health Canada

modern veterinary therapeutics llc - selamectin - solution - 360mg - selamectin 360mg - dogs

United States - English - NLM (National Library of Medicine)

modern veterinary therapeutics llc - medetomidine hydrochloride (unii: bh210p244u) (medetomidine - unii:mr15e85mqm) - placadine is indicated for use as a sedative and analgesic in dogs over 12 weeks of age to facilitate clinical examinations, clinical procedures, minor surgical procedures not requiring muscle relaxation, and minor dental procedures where intubation is not required. the iv route of administration is more efficacious for dental care. placadine should not be used in dogs with the following conditions: cardiac disease, respiratory disorders, liver or kidney diseases, dogs in shock, dogs which are severely debilitated, or dogs which are stressed due to extreme heat, cold or fatigue.

United States - English - NLM (National Library of Medicine)

modern veterinary therapeutics llc - detomidine hydrochloride (unii: 95k4lkb6qe) (detomidine - unii:7n8k34p2xh) - indications:  detomequintm is indicated for use as a sedative and analgesic to facilitate minor surgical and diagnostic procedures in mature horses and yearlings. it has been used successfully for the following: to calm fractious horses, to provide relief from abdominal pain, to facilitate bronchoscopy, bronchoalveolar lavage, nasogastric intubation, nonreproductive rectal palpations, suturing of skin lacerations, and castrations. additionally, an approved, local infiltration anesthetic is indicated for castration. contraindications:  detomequintm should not be used in horses with pre-existing av or sa block, with severe coronary insufficiency, cerebrovascular disease, respiratory disease, or chronic renal failure. intravenous potentiated sulfonamides should not be used in anesthetized or sedated horses as potentially fatal dysrhythmias may occur. information on the possible effects of detomidine hydrochloride in breeding horses is limited to uncontrolled clinical reports; therefore, this drug is not recomm

Canada - English - Health Canada

modern veterinary therapeutics llc - tulathromycin - solution - 100mg - tulathromycin 100mg - cattle; swine (pigs); sheep; cattle

United States - English - NLM (National Library of Medicine)

moderna us, inc. - cx-024414 (unii: epk39pl4r4) (cx-024414 - unii:epk39pl4r4) - there is no information on the co-administration of the moderna covid-19 vaccine with other vaccines. in order to mitigate the risks of using this unapproved product under eua and to optimize the potential benefit of the moderna covid-19 vaccine, the following items are required. use of unapproved moderna covid-19 vaccine for active immunization to prevent covid-19 under this eua is limited to the following (all requirements must be met): full eua prescribing information: contents* 11 use in specific populations 1 authorized use 11.1 pregnancy 2 dosage and administration 11.2 lactation 2.1 preparation for administration 11.3 pediatric use 2.2 administration 11.4 geriatric use 2.3 dose and schedule 11.5 use in immunocompromised individuals 3 dosage forms and strengths 13 description 4 contraindications 14 clinical pharmacology 5 warnings and precautions 14.1 mechanism of action 5.1 management of acute allergic reactions 18 clinical trial results and supporting data for eua 18.1 efficacy of two-dose primary se

United States - English - NLM (National Library of Medicine)

moderna us, inc. - cx-024414 (unii: epk39pl4r4) (elasomeran - unii:epk39pl4r4) - there is no information on the co-administration of the moderna covid-19 vaccine with other vaccines. in order to mitigate the risks of using this unapproved product under eua and to optimize the potential benefit of the moderna covid-19 vaccine, the following items are required. use of unapproved moderna covid-19 vaccine for active immunization to prevent covid-19 under this eua is limited to the following (all requirements must be met): complete and submit reports to vaers online at https://vaers.hhs.gov/reportevent.html. for further assistance with reporting to vaers, call 1-800-822-7967. the reports should include the words “moderna covid-19 vaccine eua” in the description section of the report. *serious adverse events are defined as: full eua prescribing information: contents* 11 use in specific populations 1 authorized use 11.1 pregnancy 2 dosage and administration 11.2 lactation 2.1 preparation for administration 11.3 pediatric use 2.2 administration 11.4 geriatric use 13 description 2.3 dosing and sc

United States - English - NLM (National Library of Medicine)

moderna us, inc. - elasomeran (unii: epk39pl4r4) (elasomeran - unii:epk39pl4r4) - there is no information on the co-administration of the moderna covid-19 vaccine with other vaccines. in order to mitigate the risks of using this unapproved product under eua and to optimize the potential benefit of the moderna covid-19 vaccine, the following items are required. use of unapproved moderna covid-19 vaccine for active immunization to prevent covid-19 under this eua is limited to the following (all requirements must be met): full eua prescribing information: contents* 11 use in specific populations 11.1 pregnancy 11.2 lactation 11.3 pediatric use 11.4 use in immunocompromised individuals 13 description 14 clinical pharmacology 14.1 mechanism of action 18 clinical trial results and supporting data for eua 18.1 efficacy of two-dose primary series in participants 18 years of age and older 18.2 effectiveness of two-dose primary series in participants 6 years through 11 years of age 18.3 immunogenicity in solid organ transplant recipients 19 how supplied/storage and handling 2